Clinical Trial Update: Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fludarabine-IV busulfan with or without clofarabine as conditioning for allogeneic hematopoietic stem cell transplantation in AML and M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)
• Clofarabine (clofarabine)
• Fludarabine-IV (fludarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Disorder Related to Bone Marrow Transplantation, Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2021-12-16